More common findings at prostate ultrasound
Keywords:
prostate, ultrasound, transrretal, age, infertilityAbstract
OBJECTIVE: Evaluate findings at prostate ultra-sound exams. METHODS: 737 results of transrretal ultrasound exams of patients with a range of age starting at 21 and ending at 83 years old has been analyzed from the data bank of a particular clinic, at Goiânia-GO. RESULTS: It was evidenced that 31.88% of the patients had presented prostate, seminal vesicles and bladder normal, and the average of age of these patients it was 56,58 years. Prostates presenting volume discrete or visibly increased, without any other alteration, had been found in 23,47% of the findings of men with average age of 59,18 years. Presence of nodules and evidences that suggest prostate adenoma had been verified in 7,3% of the examinations, and the average of age for this percentage is of 69,10 years. 1.89% of the patients, with age average of 59,22 years, had presented benign prostate hypertrophy. CONCLUSION: The relation between age and ultrasound’s findings that indicates risk of prostate cancer, revealed evident and directly proportional, proving what literature describes. Although this, the age did not constitute exclusive factor in the determination of this risk, because patients less than 50 years old had been presented findings that deserve clinical attention. It’s clear the necessity of investigating the multifactor cause of the prostatic alterations, allowing us to use efficient therapeutical methods that, allied with precocious diagnosis, made possible by exams as the transrretal ultrasound, can avoid risks for patient, like infertility, urinary incontinence or metastatic disease.
References
Townsend CM, Beauchamp RD, Evers BM, Mattox KL. Tratado de Cirurgia: a base biológica da prática cirúrgica moderna, 17ª edição, Saunders Elsevier, ed. Sabiston, RJ, Brasil; 2005: 2289.
Narayan, P. Neoplasias da Próstata. In: Tanagho, E. A.; Mcaninch, J. D. Urologia Geral. 13ª ed. Rio de Janeiro: Guanabara Koogan, 1994.
Sadi, A. Hiperplasia da Próstata. São Paulo, Guatuja, 1998.
Cajigas, J.; Latiff, A. Câncer de próstata: Epidemiologia y etiologia: Revisión crítica de la literatura. Urol. Colomb., 2000;2:7-12.
Barry M. J.; Fowler F. J.; O’leary M. P.; Bruskewitz R. C.; Holtgrewe H. L.; Mebust W. K.; Cockett A. T. K. The american urological symptom index for benign prostactic hyperplasia. J. urol. 1992;148:1549-57.
Dini, L. I.; Koff, W. J. Profile of prostate cancer at the general hospital of Porto Alegre. Rev. Assoc. Med. Bras. 2006;52:1.
Brum, I. S.; Spritzer, P. M.; Brentani, M. M. Molecular biology in the prostate neoplasia. Arq Bras Endocrinol Metab., 2005;49:5.
Duque, J. L. F. et al . Measurement of plasma levels of vascular endothelial growth factor in prostate cancer patients: relationship with clinical stage, Gleason score, prostate volume, and serum prostatespecific antigen. Clinics 2006;61:5.
Martins, A. C. P. et al . Free PSA and prostate volume on the diagnosis of prostate carcinoma. Acta Cir. Bras 2003;118:5.
Santos, V. C. T.; Milito, M. A.; Marchiori, E. Current role of transrectal ultrasonography in the early detection of prostate cancer. Radiol Bras 2006;39:3.
Kokeny, G. P. et al . Prostate adenocarcinoma: is transrectal ultrasound diffuse hypoechoic appearance of the prostate an important finding? Radiol Bras 2001;34:4.
Smith JA. Transrectal ultrasonography for the detection and staging of the carcinoma of the prostate. J Clin Ultrasound. 1996;24:455-61.
Simono MRS, Perez RG, Collar TLR, Lopez AG. Utilidad del ultrasonido transrectal en el diagnóstico del cáncer prostático. Rev Cub Med Mil [online]. 2007, vol.36, n.1 [citado 2010-04-19], pp. 0-0 .
Fournier G, Valeri A, Mangin P, Cussenot O. Prostate cancer: Diagnosis and staging. Ann Urol 2004;38:207-24.
